Evidence map›Paper›PMID 38855181›Full record

ArticleTheranostics2024

Platelet-targeted thromboprophylaxis with a human serum albumin fusion drug: Preventing thrombosis and reducing cardiac ischemia/reperfusion injurywithout bleeding complications.

Yuyang Song, Laura A Bienvenu, Viktoria Bongcaron, Shania A Prijaya, Ana C Maluenda, Aidan P G Walsh, James D McFayden, Geoffrey A Pietersz, Karlheinz Peter, Xiaowei Wang

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Theranostics, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Review
  5. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

Yuyang SongMolecular Imaging and Theranostics Laboratory, Baker Heart and Diabetes Institute, Melbourne, VIC, Australia.
Laura A BienvenuMolecular Imaging and Theranostics Laboratory, Baker Heart and Diabetes Institute, Melbourne, VIC, Australia.
Viktoria BongcaronMolecular Imaging and Theranostics Laboratory, Baker Heart and Diabetes Institute, Melbourne, VIC, Australia.
Shania A PrijayaMolecular Imaging and Theranostics Laboratory, Baker Heart and Diabetes Institute, Melbourne, VIC, Australia.
Ana C MaluendaAtherothrombosis and Vascular Biology Laboratory, Baker Heart and Diabetes Institute, Melbourne, VIC, Australia.
Aidan P G WalshMolecular Imaging and Theranostics Laboratory, Baker Heart and Diabetes Institute, Melbourne, VIC, Australia.
James D McFaydenDepartment of Cardiometabolic Health, University of Melbourne, VIC, Australia.
Geoffrey A PieterszDepartment of Cardiometabolic Health, University of Melbourne, VIC, Australia.
Karlheinz PeterDepartment of Cardiometabolic Health, University of Melbourne, VIC, Australia.
Xiaowei WangMolecular Imaging and Theranostics Laboratory, Baker Heart and Diabetes Institute, Melbourne, VIC, Australia.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

Blood PlateletsHemorrhageSerum Albumin, HumanThrombosisAnimalsAnticoagulantsDisease Models, AnimalHumansMaleMiceMice, Inbred C57BLMyocardial InfarctionMyocardial Reperfusion InjuryRecombinant Fusion ProteinsSingle-Chain AntibodiesAnticoagulantsRecombinant Fusion ProteinsSerum Albumin, HumanSingle-Chain Antibodiesanticoagulantantiplatelettargeted drug deliverythromboprophylaxisthrombosis

Identifiers

PMID38855181
PMCPMC11155409

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.